https://doi.org/10.1007/s00330-023-09681-2
W
Weiping Hong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
190
Citations
9
h-index
8
i10-index
Weiping Hong is an academic researcher from Jiangnan University. The author has contributed to research in topics: Brain Metastases and Treatment & Lung Cancer Treatments and Mutations & Glioma Diagnosis and Treatment. The author has an h-index of 9, co-authored 57 publications.
ORCID: 0009-0009-9856-5854Papers by this author
worksAtypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling
2023 · European Radiology · 14 citations
EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome
2022 · Frontiers in Oncology · 11 citations
https://doi.org/10.3389/fonc.2022.902664
Mechanical testing and microstructural analysis of wire laser beam directed energy deposited steel plates
2025 · Materials & Design · 6 citations
https://doi.org/10.1016/j.matdes.2025.114141
Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome
2023 · BMC Cancer · 3 citations
https://doi.org/10.1186/s12885-023-11627-2
Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532]
2025 · Heliyon · 1 citations
https://doi.org/10.1016/j.heliyon.2025.e43247
TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases
2024 · Heliyon · 0 citations
https://doi.org/10.1016/j.heliyon.2024.e36532
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat